loading

Atea Pharmaceuticals Inc Stock (AVIR) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
49.89%
69.81
46.57 40.78 35.23 41.57
Depreciation and Amortization
0.00%
0.104
0.104 0.104 0.104 0.104
Operating Income/Loss
49.89%
-69.81
-46.57 -40.78 -35.23 -41.57
Income/Loss From Continuing Operations Before Tax
62.15%
-62.94
-38.81 -32.92 -27.93 -35.27
Income Tax Expense/Benefit
33.81%
0.231
0.349 0.221 0.251 0.197
Income/Loss From Continuing Operations After Tax
61.29%
-63.17
-39.16 -33.14 -28.18 -35.47
Net Income/Loss
61.29%
-63.17
-39.16 -33.14 -28.18 -35.47
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
544.03K%
83.92
0.0154 83.40 83.40 83.33
Diluted Average Shares
544.03K%
83.92
0.0154 83.40 83.40 83.33
Basic Earnings Per Share
59.57%
-0.75
-0.47 -0.40 -0.34 -0.43
Diluted Earnings Per Share
59.57%
-0.75
-0.47 -0.40 -0.34 -0.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):